tiprankstipranks
Clinigence Holdings Inc (NUTX)
:NUTX
US Market
Holding NUTX?
Track your performance easily

Clinigence Holdings (NUTX) Earnings Dates, Call Summary & Reports

200 Followers

Earnings Data

Report Date
Feb 27, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-0.12
Last Year’s EPS
-7.5
Same Quarter Last Year
Based on 3 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 24, 2021
|
% Change Since: 30.88%
|
Next Earnings Date:Apr 02, 2021
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with notable revenue and EBITDA growth, alongside improvements in operational efficiency and cash flow. However, challenges remain with increased net losses and a decline in the Population Health division revenue. The company's strategic initiatives and cost control measures show promise for future performance.
Company Guidance
During the third quarter of 2024, Nutex Health Inc. reported significant financial and operational metrics, reflecting robust growth and strategic advancements. Total revenue reached $78.8 million, marking a 26% increase compared to the same period last year. This growth was driven by a 20.7% revenue increase from mature hospitals and the successful ramp-up of four new hospitals opened in 2023. Despite a net loss of $8.8 million, impacted by a $6.7 million noncash loss on warrant liability and a $2 million noncash stock-based compensation expense, the company achieved a positive adjusted EBITDA of $13.5 million, representing a remarkable 938% increase from the previous year. The hospital division reported 41,668 patient visits, an 11.3% increase year-over-year, with mature hospitals contributing a 3.8% increase. Nutex Health also highlighted strategic initiatives focusing on the expansion of new hospitals, service enhancements in mature hospitals, improved reimbursement processes, and operational efficiencies. The company remains optimistic about its future trajectory, driven by continued innovation, community engagement, and a commitment to operational excellence.
Significant Revenue Growth
Total revenue for Q3 2024 was $78.8 million, a 26% increase from $62.7 million in Q3 2023.
Adjusted EBITDA Increase
Adjusted EBITDA for Q3 2024 was $13.5 million, up 938% from $1.3 million in Q3 2023.
Growth in Hospital Visits
Hospital division reported 41,668 visits in Q3 2024, an 11.3% increase over Q3 2023.
Operational Efficiency Improvements
Facility operating costs reduced to 72.2% of total revenue in Q3 2024 compared to 88.7% in Q3 2023.
Strong Cash Flow
Net cash from operating activities was $23.1 million for Q3 2024, up from $3 million in Q3 2023, a 67% increase.
Successful Cost Control Measures
Implemented cost-saving strategies in labor, supply chain, and contract services.
---

Clinigence Holdings (NUTX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NUTX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 02, 20212020 (Q4)
- / -0.24
-0.27211.03% (+0.03)
May 24, 20212021 (Q1)
- / -
-0.272
Aug 16, 20212021 (Q2)
- / -0.07
0.049-238.78% (-0.12)
Nov 15, 20212021 (Q3)
- / -0.04
0.339-113.27% (-0.38)
Apr 01, 20222021 (Q4)
- / -0.10
-0.24259.92% (+0.14)
May 23, 20222022 (Q1)
- / -
-0.242
Aug 22, 20222022 (Q2)
- / -4.50
-10.26456.14% (+5.76)
Nov 22, 20222022 (Q3)
- / -94.50
-6.738-1302.49% (-87.76)
Mar 02, 20232022 (Q4)
-2.25 / -3.00
-14.54479.37% (+11.54)
May 15, 20232023 (Q1)
-2.25 / -1.50
-52.0997.12% (+50.59)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

NUTX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 07, 2024$28.89$31.56+9.24%
Aug 08, 2024$7.90$10.10+27.85%
May 08, 2024$6.47$6.60+2.01%
Mar 28, 2024$14.38$14.25-0.90%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Clinigence Holdings Inc (NUTX) report earnings?
Clinigence Holdings Inc (NUTX) is schdueled to report earning on Feb 27, 2025, TBA Not Confirmed.
    What is Clinigence Holdings Inc (NUTX) earnings time?
    Clinigence Holdings Inc (NUTX) earnings time is at Feb 27, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NUTX EPS forecast?
          NUTX EPS forecast for the fiscal quarter 2024 (Q4) is -0.12.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis